BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $53,857,000 | -29.1% | 356,257 | -31.7% | 0.01% | -10.0% |
| Q2 2022 | $75,999,000 | +24.3% | 521,580 | +1.1% | 0.01% | +66.7% |
| Q1 2022 | $61,155,000 | -4.8% | 515,771 | +10.7% | 0.01% | 0.0% |
| Q4 2021 | $64,216,000 | +9.0% | 465,977 | +9.8% | 0.01% | 0.0% |
| Q3 2021 | $58,928,000 | +63.7% | 424,217 | +14.4% | 0.01% | +100.0% |
| Q2 2021 | $35,990,000 | +240.7% | 370,729 | +139.9% | 0.00% | +200.0% |
| Q1 2021 | $10,563,000 | -20.3% | 154,547 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $13,261,000 | +688.4% | 154,716 | +497.9% | 0.00% | – |
| Q3 2020 | $1,682,000 | -9.8% | 25,876 | +1.4% | 0.00% | – |
| Q2 2020 | $1,865,000 | +108.8% | 25,510 | -2.8% | 0.00% | – |
| Q1 2020 | $893,000 | -36.4% | 26,238 | +1.8% | 0.00% | – |
| Q4 2019 | $1,403,000 | +46.6% | 25,776 | +12.4% | 0.00% | – |
| Q3 2019 | $957,000 | +16.0% | 22,930 | +21.8% | 0.00% | – |
| Q2 2019 | $825,000 | -91.8% | 18,831 | -95.0% | 0.00% | -100.0% |
| Q4 2017 | $10,119,000 | -27.6% | 375,048 | +0.3% | 0.00% | 0.0% |
| Q3 2017 | $13,978,000 | +12.7% | 373,948 | -24.6% | 0.00% | 0.0% |
| Q2 2017 | $12,403,000 | – | 496,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |